Position history for MetLife Investment Management, LLC's holdings in IOVANCE BIOTHERAPEUTICS INC
MetLife Investment Management, LLC holds 184,399 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), worth $647,240 as of 2026-Q1. The position was increased (+8.0% shares). IOVA represents 0.0% of MetLife Investment Management, LLC's portfolio.
Current Value
$647,240
Current Shares
184,399
Total Value Change
-$527,016
Total Shares Change
+37,983
Other major holders of IOVA: ARK Investment Management LLC, FRANKLIN RESOURCES INC, Avoro Capital Advisors LLC
Increased |
| 184,399 |
+8.0% |
| $647,240 |
| 0.0% |
| $3.74 |
26 |
| 2025-Q4 | Increased | 170,782 | +20.5% | $466,235 | 0.0% | $2.77 | 29 |
| 2025-Q3 | Decreased | 141,686 | -6.2% | $307,459 | 0.0% | $2.23 | 0 |
| 2025-Q2 | Decreased | 150,974 | -0.1% | $259,674 | 0.0% | $1.69 | 0 |
| 2025-Q1 | Decreased | 151,206 | -8.8% | $503,516 | 0.0% | $3.56 | 0 |
| 2024-Q4 | Increased | 165,842 | +13.3% | $1.2M | 0.0% | $7.17 | 29 |
| 2024-Q3 | Unchanged | 146,416 | 0.0% | $1.4M | 0.0% | $9.61 | 0 |
| 2024-Q2 | Increased | 146,416 | +20.9% | $1.2M | 0.0% | $8.02 | 30 |